NBT Bank N A NY Reduces Stake in UnitedHealth Group Incorporated (NYSE:UNH)

NBT Bank N A NY reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 11.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,305 shares of the healthcare conglomerate's stock after selling 2,280 shares during the period. NBT Bank N A NY's holdings in UnitedHealth Group were worth $9,063,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of UNH. NewSquare Capital LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new position in UnitedHealth Group during the 4th quarter worth approximately $26,000. Hurley Capital LLC purchased a new stake in UnitedHealth Group in the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd purchased a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $30,000. Finally, Promus Capital LLC purchased a new stake in UnitedHealth Group in the 4th quarter valued at $32,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Down 1.8%

NYSE UNH opened at $307.84 on Tuesday. The business has a 50 day moving average price of $381.74 and a two-hundred day moving average price of $470.20. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a market cap of $279.25 billion, a PE ratio of 19.86, a P/E/G ratio of 1.37 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. During the same period in the previous year, the company earned $6.91 earnings per share. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be paid a dividend of $2.21 per share. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a dividend yield of 2.87%. The ex-dividend date is Monday, June 16th. UnitedHealth Group's dividend payout ratio is 37.02%.

Insider Buying and Selling

In other news, CFO John F. Rex acquired 17,175 shares of the stock in a transaction that occurred on Friday, May 16th. The stock was purchased at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the acquisition, the chief financial officer now directly owns 203,796 shares in the company, valued at $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Timothy Patrick Flynn bought 1,533 shares of the firm's stock in a transaction dated Wednesday, May 14th. The stock was purchased at an average price of $320.80 per share, with a total value of $491,786.40. Following the transaction, the director now owns 6,033 shares in the company, valued at approximately $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders purchased 109,408 shares of company stock worth $31,607,768. Insiders own 0.28% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on UNH. Morgan Stanley decreased their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. Truist Financial reiterated a "buy" rating and issued a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Piper Sandler decreased their price target on UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a report on Tuesday, June 3rd. Royal Bank of Canada cut their price objective on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. Finally, JPMorgan Chase & Co. dropped their price target on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating on the stock in a research note on Thursday, May 15th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $426.52.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.